The Greek NMVO (National Medicines Verification Organization) has been established and regulatory measures have been initiated, as it is planned to be fully operative by the deadline of 9th February 2025.
To provide detailed information to the Greek stakeholders, EMVO organized a workshop last year. Regarding the technical details and information for onboarding to the EMVS, EMVO plans a separate workshop in cooperation with Greek NMVO in Q2/Q3 of 2024.
Under discussion between Greek stakeholders stays the topic of the incorporation of parallel traders and wholesalers.
Serialization requirements are mandatory, including GS1 2D Data Matrix and anti-tampering device.
2D DataMatrix
Human-readable part